Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-04-26

Clinical Trial Update: Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating leucine-enriched essential amino acid powder added to a classic ketogenic diet for refractory epilepsy and drug-resistant epilepsy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leucine Enriched Essential Amino Acid Powder (Leucine-enriched essential amino acid powder)

Snippet

Sponsor: Elizabeth Anne Thiele | Conditions: Refractory Epilepsy, Drug Resistant Epilepsy | Phase 1 | Status: NOT_YET_RECRUITING